Drugs / Suphentanil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02664142 | Jun 2015 → Sep 2017 | — | University Hospital Ostrava | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Suphentanil | “analgesic component: Suphentanil (continuous dose of 0.1-0.3ug/kg iv. every 20-30 min)” NCT02664142 ↗ |
| Route | Intravenous | “analgesic component: Suphentanil (continuous dose of 0.1-0.3ug/kg iv. every 20-30 min)” NCT02664142 ↗ |